| Upgrade to boost capacity by up to 23 percent for moisture-barrier
film |
| |
| PHILADELPHIA, March 26, 2008 -- Honeywell (NYSE: HON) announced today that
it will expand production of Aclar® film to meet growing demand for the clear,
moisture-barrier material, which is used extensively in pharmaceutical
packaging. |
| |
| An upgrade of existing production capability, combined with overall
productivity improvements, is expected to boost Aclar production by up to 23
percent by end of 2008 at the business’ Pottsville, Pa. facility. |
| |
| “This is another step in our continued strategy to invest to meet the
packaging needs of the pharmaceutical industry now and in the future,” said
Jeff Czarnecki, global segment leader for the specialty films segment of
Honeywell Performance Products. Czarnecki noted that the business implemented
productivity improvements at the Pottsville site in 2007 which also boosted
capacity. |
| |
| Rick Knight, global business manager for healthcare, said pharmaceutical
companies worldwide continue to demand thermoformed packaging material with
superior barrier capabilities. “Honeywell is committed to supporting
pharmaceutical companies globally as they introduce new products to the
marketplace,” Knight said. |
| |
| The announcement was made at INTERPHEX™, the world’s largest and most
comprehensive pharmaceutical conference and exhibition. The event focuses on
leading-edge technology, education, and sourcing of products and services that
drive scientific innovation for life sciences manufacturing. |
| |
| As part of its commitment to the pharmaceutical industry, Honeywell is
continuing its technical training and educational series to address critical
aspects of thermoform packaging. The program consists of half- and one-day
workshops. |
| |
| Aclar is a polychlorotrifluoroethylene (PCTFE) fluoropolymer film that has
excellent moisture barrier and chemical stability. Aclar film is crystal clear,
biochemically inert, chemical-resistant, nonflammable, and plasticizer- and
stabilizer-free. |
| |
| In addition to Aclar, Honeywell Specialty Films manufactures Capran®
biaxially oriented nylon film, also known as biaxially oriented polyamide
(BOPA) film; Capran® heat stabilized nylon film; Aclon™ fluoropolymer resins,
which provide the highest moisture barrier of any clear thermoplastic resins;
and Honeywell PCTFE, ECTFE and PMP barrier films for high performance
industrial applications. |
| |
| Honeywell Specialty Materials, based in Morristown, N.J., is a $4.9
billion, global leader in providing customers with high-performance specialty
materials, including fluorine products; specialty films and additives; advanced
fibers and composites; intermediates; specialty chemicals; electronic materials
and chemicals; and technologies and materials for petroleum refining. |
| |
| Honeywell International is a $36 billion diversified technology and
manufacturing leader, serving customers worldwide with aerospace products and
services; control technologies for buildings, homes and industry; automotive
products; turbochargers; and specialty materials. Based in Morris Township,
N.J., Honeywell’s shares are traded on the New York, London and Chicago Stock
Exchanges. For additional information, please visit www.honeywell.com. |
| |
| This report contains “forward-looking statements” within the meaning of
Section 21E of the Securities Exchange Act of 1934. All statements, other than
statements of fact, that address activities, events or developments that we or
our management intend, expect, project, believe or anticipate will or may occur
in the future are forward-looking statements. Forward-looking statements are
based on management’s assumptions and assessments in light of past experience
and trends, current conditions, expected future developments and other relevant
factors. They are not guarantees of future performance, and actual results,
developments and business decisions may differ from those envisaged by our
forward-looking statements. Our forward-looking statements are also subject to
risks and uncertainties, which can affect our performance in both the near- and
long-term. We identify the principal risks and uncertainties that affect our
performance in our Form 10-K and other filings with the Securities and Exchange
Commission. |
| |
| Contact: |
| Robert Donohoe |
| 973-455-4114 |
| Robert.Donohoe@honeywell.com |
| |
